TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
STTK

Shattuck Labs Inc

Healthcare · Biotechnology

4.70$ -3.3% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Shattuck Labs Inc (STTK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.0% of the shares are freely tradable; institutional investors hold 67.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 67.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 68.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 102Mio.

Largest Shareholders

Institutions

Institutions STTK
Name Stake (%) Shares Change (%) Date
T. Rowe Price Investment Management,Inc. 13.19 13,432,540 +36.2 06/30/2026
Adage Capital Partners Gp LLC 7.98 8,122,179 +74.9 06/30/2026
Redmile Group, LLC 6.77 6,892,033 +24.4 06/30/2026
Orbimed Advisors LLC 6.19 6,306,127 +0.0 06/30/2026
Prosight Management, LP 5.85 5,957,877 +19.1 06/30/2026
BlackRock Inc 3.87 3,935,810 +670.5 06/30/2026
Frazier Life Sciences Management, L.P. 3.68 3,750,000 +0.0 06/30/2026
NEXTBio Capital Management LP 3.66 3,727,348 +18.3 06/30/2026
Deep Track Capital, LP 3.64 3,706,734 +0.0 06/30/2026

Funds

Funds STTK
Name Stake (%) Shares Change (%) Date
T. Rowe Price Small-Cap Stock 3.42 3,487,102 +12.1 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?